3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Breast
1
Conditions
Ovarian Neoplasms
1
Fasting
1
Breast Neoplasms
1
Interventions
Paclitaxel
35
Carboplatin
35
Bevacizumab
14
olaparib
13
niraparib
11
apatinib
11
Gemcitabine
10
liposomal doxorubicin
9
Hyperthermic Intraperitoneal Chemotherapy
9
Cisplatin
9
pembrolizumab
8
Cyclophosphamide
8
fludarabine
7
Etoposide
7
Topotecan
6
fluzoparib
5
Surveys and Questionnaires
5
Drug Therapy
5
Albumin-Bound Paclitaxel
5
anlotinib
4
Immunohistochemistry
4
Ifosfamide
4
Doxorubicin
4
Docetaxel
4
Cytoreduction Surgical Procedures
4
Taxes
3
Surgical Procedures, Operative
3
Poly(ADP-ribose) Polymerase Inhibitors
3
Neoadjuvant Therapy
3
Laparoscopy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Ovarian Neoplasms
×
Diet, Vegan
×
Clear all
NCT03162289
2022-12-13
FIT2
Charite University, Berlin, Germany
Phase NA
Unknown
150 enrolled